4 results match your criteria: "Bengbu Third People's Hospital Bengbu[Affiliation]"
Phloretin attenuates inflammation induced by subarachnoid hemorrhage through regulation of the TLR2/MyD88/NF-kB pathway.
Sci Rep
November 2024
Department of Neurosurgery, Bengbu Third People's Hospital Bengbu, 233000, Anhui, China.
Article Synopsis
- Subarachnoid hemorrhage (SAH) is a serious stroke type linked to high death rates and neuroinflammation, but the role of phloretin, a natural flavonoid with anti-inflammatory effects, in SAH is not well understood.
- Researchers used experimental models to evaluate the effects of phloretin in SAH and analyzed public datasets to identify important genes connected to the condition.
- The study found that phloretin improves recovery outcomes and reduces inflammation in SAH models, working by blocking the TLR2/MYD88/NF-κB signaling pathway.
A broad ligament pregnancy had been managed by laparoscopy. A 2-cm ectopic pregnancy sac was located in the posterior lobe of the left broad ligament. We identified and separated the ipsilateral ureter during the operation because the ectopic gestational sac was very close to the ureter.
View Article and Find Full Text PDFExpression of AGGF1 and Twist1 in hepatocellular carcinoma and their correlation with vasculogenic mimicry.
Int J Clin Exp Pathol
July 2020
Department of Pathology, The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China.
Background: The most common reason for hepatocellular carcinoma (HCC) treatment failure is recurrence and metastasis. AGGF1 (a promoting gene of tumor metastasis), vasculogenic mimicry (VM, new blood supply formation in malignant tumors), and Twist1 (an evolutionarily conserved basic helix-loop-helix transcription factor) are all valuable factors for metastasis and prognosis in diverse common human cancers. However, the correlation of AGGF1, Twist1, and VM in HCC is still unclear.
View Article and Find Full Text PDFSuperficial CD34-positive fibroblastic tumor: report of two cases and review of literature.
Int J Clin Exp Pathol
January 2020
Department of Pathology, The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China.
Background: We studied the clinicopathologic features of superficial CD34-positive fibroblastic tumor (SCPFT), which is a newly described neoplasm, to enhance the recognition and diagnostic level of the disease.
Case Presentation: We herein report two cases of superficial CD34-positive fibroblastic tumors in a 33-year-old man and a 30-year-old man. The 33-year-old man presented with a slow-growing subcutaneous nodule 5.